Biopharmaceutical company AbbVie Inc. will buy Pharmacyclics, which specializes in cancer treatment, for $21 billion.
March 11, 2015 at 09:28 PM
1 minute read
The original version of this story was published on Law.Com
North Chicago, Illinois-based biopharmaceutical company AbbVie Inc. will buy Sunnyvale, California-based Pharmacyclics, which specializes in cancer treatment, for $21 billion.
AbbVie will purchase Pharmacyclics for $261.25 per share, which represents a 13 percent premium over the target’s closing price Wednesday.
Presented by BigVoodoo
GlobeSt. Women of Influence Conference celebrates the women who drive the commercial real estate industry forward.
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Description of WorkPosition Definition: The Office of Corporation Counsel seeks a seasoned contract and transactional attorney to prepare, r...
DEPUTY SOLICITOR GENERAL Position No: 125-31487 Salary Range: Commensurate with Experience Closing Date: July 31, 2024. Click...
McCarter & English, LLP is actively seeking a biotechnology patent associate or patent agent with an advanced degree in biology, biochem...
